Investorideas.com Newswire

Investorideas.com Newswire
Be one of the most talked about companies (stocks) on social media

Investorideas.com newswire, biotech stocks and industry

Wednesday, July 28, 2010

Investorideas.com - Biotech/ Pharma Stocks; Most Active Trading News: OTC Volume Leaders; ($0.25-$0.50): (OTCBB: GHLV), (OTCBB: IMGG), (OTCBB: NPHC), (OTCBB: CHTL)

Investorideas.com - Biotech/ Pharma Stocks; Most Active Trading News: OTC Volume Leaders; ($0.25-$0.50): (OTCBB: GHLV), (OTCBB: IMGG), (OTCBB: NPHC), (OTCBB: CHTL)


Note to Editors: The Following Is an Investment Opinion Being Issued by OTC VOLUME LEADERS


Subscribe to Investor Ideas Newswire


Visit this company: www.otcvolumeleaders.com
Point Roberts, WA (Investorideas.com Newswire) July 28, 2010 - OTC VOLUME LEADERS reports on the most active trading stocks on the OTCBB. OTC Volume leaders ($0.25-$0.50) include Global Health Ventures Inc. (OTCBB: GHLV), Imaging3 Inc . (OTCBB: IMGG), Nutra Pharma Corporation (OTCBB: NPHC), and China Tel Group Inc . (OTCBB: CHTL).

Sign up for Free OTC Volume Leader Alerts!http://bit.ly/otcvolumeleaders


OTC / Market Commentary:
Sectors include Biotech/ Pharma Stocks
One of the OTCBB volume leaders: Global Health Ventures Inc. (OTCBB: GHLV)"Global Health Ventures is a specialty pharma focused on the life style products. The company has a new proprietary platform technology for drug delivery via the sublingual (under the tongue) route. This unique method delivers drugs to the bloodstream quickly with minimal drug breakdown in the liver or gastro-intestinal system, a process that can greatly reduce side effects associated with the drug. The Company's lead therapeutic product is a male sexual enhancement drug that is delivered via sublingual route and is called X-Excite. In experimental studies, X-Excite has been shown to reach blood stream rapidly, producing maximal effect and having less of the unwanted side effects which are associated with the standard oral administration route drugs. X-Excite is presently in clinical trials in Europe. The Company also uses the same technology to deliver a vast number of other FDA approved drugs where they are needed to act rapidly. These include, stress relief, sleeping disorders, pain killers, anti-allergy medications, energy boosters and addiction replacement therapies."


Market Snapshot: (at time of release)

Dow 10,522.18 -15.51 -0.15%
Nasdaq 2,275.35 -12.90 -0.56%
S&P 500 1,109.82 -4.02 -0.36%
10 Yr Bond(%) 3.0410% -0.0600
Oil 76.80 -0.70 -0.90%
Gold 1,158.00 0.00 0.00%

OTCBB Investors: Take the few minutes to register with us at To sign up for free Newsletter http://bit.ly/otcvolumeleaders and get access to info on hundreds of the most active OTCBB companies and keep up to date with developments of the companies.
OTC VOLUME LEADERS provides investors with daily market updates showcasing the most actively traded OTCBB Companies. We strive to provide you with the most up-to-date market information and activity by searching through hundreds of OTCBB companies in order to provide you information on the best of these companies. The goal is to continually find tomorrow’s market leading companies, today!


OTCVolumeleaders.com has not been compensated by any of the above mentioned companies. We act as an independent research portal and are aware that all investment entails inherent risks.
Please view the full disclaimer: http://www.otcvolumeleaders.com/Source http://www.otcvolumeleaders.com/Follow OTC Volume Leaders on Twitter.com http://twitter.com/OTCVolumeLeader


Visit the OTC showcase profile at Investorideas.com Request News and Info on OTC Disclosure, Disclaimer/ OTC is a paid advertising client on Investorideas.com.

More Info:
Published at www.Investorideas.com - Global research by sectors
If you have any questions regarding information in this press release please contact the company listed in the press release.
Disclaimer: The following news is paid for and /or published as information only for our readers. Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.aspInvestorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp

No comments:

Post a Comment